[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1063 Introduced in House (IH)]

<DOC>






115th CONGRESS
  1st Session
                                H. R. 1063

   To ensure that an individual who is transitioning from receiving 
  medical treatment furnished by the Secretary of Defense to medical 
 treatment furnished by the Secretary of Veterans Affairs receives the 
          pharmaceutical agents required for such transition.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 15, 2017

  Mr. O'Rourke (for himself, Mr. Coffman, Mr. Jones, Mr. Peters, Miss 
 Rice of New York, and Ms. Titus) introduced the following bill; which 
           was referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL


 
   To ensure that an individual who is transitioning from receiving 
  medical treatment furnished by the Secretary of Defense to medical 
 treatment furnished by the Secretary of Veterans Affairs receives the 
          pharmaceutical agents required for such transition.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Veteran Prescription Continuity 
Act''.

SEC. 2. IMPROVEMENT TO TRANSITION OF CARE OF VETERANS.

    Section 715 of the National Defense Authorization Act for Fiscal 
Year 2016 (Public Law 114-92; 10 U.S.C. 1074g note) is amended--
            (1) by redesignating subsections (c) through (f) as 
        subsections (d) through (g), respectively; and
            (2) by inserting after subsection (b) the following new 
        subsection (c):
    ``(c) Other Pharmaceutical Agents.--
            ``(1) Critical for transition.--The Secretary of Veterans 
        Affairs shall furnish to an individual who is transitioning 
        from receiving treatment furnished by the Secretary of Defense 
        to treatment furnished by the Secretary of Veterans Affairs 
        pursuant to chapter 17 of title 38, United States Code, any 
        pharmaceutical agent not included in the joint uniform 
        formulary if a health care provider of the Department of 
        Defense determines that such pharmaceutical agent is critical 
        for such transition.
            ``(2) Duration.--The Secretary of Veterans Affairs shall 
        furnish to an individual a pharmaceutical agent under paragraph 
        (1) during the period--
                    ``(A) beginning on the date on which the individual 
                is enrolled in the health care system of the Department 
                of Veterans Affairs established under section 1705 of 
                title 38, United States Code; and
                    ``(B) ending on the date on which a health care 
                provider of the Department determines that the 
                individual does not require such pharmaceutical 
                agent.''.
                                 <all>